Howard Capital Management (New York)’s Merck MRK Stock Holding History

Howard Capital Management (New York)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$20.1M	Buy	257,811 +4,441	+2%	+$340K	2.26%	22
2020 Q3	$20.1M	Sell	253,370 -37,823	-13%	-$2.96M	2.53%	14
2020 Q2	$21.5M	Buy	291,193 +4,779	+2%	+$360K	2.86%	9
2020 Q1	$21M	Sell	286,414 -4,603	-2%	-$362K	3.59%	5
2019 Q4	$25.3M	Buy	291,017 +650	+0.2%	+$53.4K	3.16%	6
2019 Q3	$23.3M	Sell	290,367 -327	-0.1%	-$26.2K	3.32%	6
2019 Q2	$23.3M	Buy	290,694 +3,200	+1%	+$245K	3.17%	7
2019 Q1	$22.8M	Buy	287,494 +10,620	+4%	+$794K	3.22%	6
2018 Q4	$20.2M	Sell	276,874 -370	-0.1%	-$26.1K	3.33%	6
2018 Q3	$18.8M	Buy	277,244 +808	+0.3%	+$51.5K	2.5%	8
2018 Q2	$16M	Buy	276,436 +19	+0%	+$1.07K	2.3%	16
2018 Q1	$14.4M	Buy	276,417 +5,723	+2%	+$309K	2.09%	20
2017 Q4	$14.5M	Sell	270,694 -57	-0%	-$3.16K	2.14%	20
2017 Q3	$16.5M	Sell	270,751 -2,899	-1%	-$176K	2.55%	10
2017 Q2	$16.7M	Sell	273,650 -1,382	-0.5%	-$84.1K	2.63%	8
2017 Q1	$16.7M	Buy	275,032 +975	+0.4%	+$59.2K	2.78%	10
2016 Q4	$15.4M	Sell	274,057 -58	-0%	-$3.39K	2.73%	11
2016 Q3	$16.3M	Sell	274,115 -1,765	-0.6%	-$103K	2.97%	10
2016 Q2	$15.2M	Buy	275,880 +1,769	+0.6%	+$94.1K	2.91%	9
2016 Q1	$13.8M	Sell	274,111 -1,877	-0.7%	-$91.9K	2.72%	10
2015 Q4	$13.9M	Sell	275,988 -896	-0.3%	-$45.2K	2.73%	10
2015 Q3	$13M	Buy	276,884 +165	+0.1%	+$8.77K	2.65%	10
2015 Q2	$15M	Sell	276,719 -3,307	-1%	-$185K	2.86%	6
2015 Q1	$15.4M	Sell	280,026 -1,084	-0.4%	-$61.4K	2.96%	5
2014 Q4	$15.2M	Sell	281,110 -68,841	-20%	-$3.84M	2.93%	6
2014 Q3	$19.8M	Sell	349,951 -1,185	-0.3%	-$66.5K	3.95%	3
2014 Q2	$19.4M	Sell	351,136 -9,838	-3%	-$537K	3.82%	3
2014 Q1	$19.6M	Buy	360,974 +6,854	+2%	+$355K	3.85%	3
2013 Q4	$16.9M	Buy	354,120 +23,122	+7%	+$1.06M	3.47%	3
2013 Q3	$15M	Buy	330,998 +10,752	+3%	+$491K	3.68%	3
2013 Q2	$14.2M	Buy	+320,246	New	+$14.3M	3.71%	3

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Howard Capital Management (New York)'s MRK Position: Q4 2020 in Review

Howard Capital Management (New York) increased its Merck (MRK) stake by 1.8% in Q4 2020, buying an estimated $340K and bringing the position to 257,811 shares worth $20.1M. The position accounts for 2.26% of the portfolio, ranked #22.

Howard Capital Management (New York) first reported a position in MRK in Q2 2013 and has held it in 31 quarters since. The position peaked at $25.3M in Q4 2019. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

Howard Capital Management (New York) held 257,811 shares of Merck worth $20.1M as of Q4 2020.
Howard Capital Management (New York) bought 4,441 Merck shares in Q4 2020, an estimated $340K.
Merck made up 2.26% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #22 holding.
Howard Capital Management (New York) first reported a position in Merck in Q2 2013 and has held it in 31 quarters since.
Howard Capital Management (New York)'s Merck position peaked at $25.3M in Q4 2019.
2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.